BIOREM Inc.
BIRMF
$2.15
-$0.07-3.15%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 48.73% | 82.62% | -25.14% | 27.76% | -24.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.73% | 82.62% | -25.14% | 27.76% | -24.91% |
| Cost of Revenue | 54.63% | 43.12% | -18.81% | 20.59% | -17.81% |
| Gross Profit | 29.46% | 273.45% | -37.57% | 52.18% | -41.42% |
| SG&A Expenses | 20.81% | 64.63% | -24.22% | 29.14% | -20.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -100.00% | -- | -- |
| Total Operating Expenses | 46.96% | 47.63% | -19.41% | 22.00% | -18.33% |
| Operating Income | 161.10% | 843.44% | -47.65% | 103.87% | -87.76% |
| Income Before Tax | 455.97% | 1,445.97% | -47.71% | 116.75% | -89.79% |
| Income Tax Expenses | 447.31% | 1,084.76% | -47.71% | 116.87% | -89.63% |
| Earnings from Continuing Operations | 459.07% | 1,591.64% | -47.71% | 116.79% | -89.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 459.07% | 1,591.64% | -47.71% | 116.79% | -89.85% |
| EBIT | 161.10% | 843.44% | -47.65% | 103.87% | -87.76% |
| EBITDA | 37.21% | 722.78% | -46.58% | 96.35% | -69.28% |
| EPS Basic | 462.50% | 1,679.49% | -48.38% | 112.66% | -90.18% |
| Normalized Basic EPS | 442.86% | 1,535.29% | -48.44% | 111.85% | -89.86% |
| EPS Diluted | 464.29% | 3,015.00% | -47.98% | 118.94% | -90.07% |
| Normalized Diluted EPS | 458.33% | 1,635.09% | -47.61% | 115.79% | -89.92% |
| Average Basic Shares Outstanding | -0.02% | -5.02% | 1.31% | 2.12% | 3.17% |
| Average Diluted Shares Outstanding | -1.50% | -11.63% | -0.06% | 0.44% | 2.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |